tm logo
VALENCE LABS
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 02 Jul 2024

Last Applicant/ Owned by

41 South Rio Grande Street

Salt Lake City

UT

84101

Serial Number

98137246 filed on 17th Aug 2023

Registration Number

N/A

Correspondent Address

David Johnson

David Johnson WORKMAN NYDEGGER

SUITE 1000

SALT LAKE CITY, UT 84111

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VALENCE LABS

Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Te Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98137246

Mark Type

No Service Mark

Attorney Docket Number

No 21140.64

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Jul 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
02th Jul 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
02th Jul 2024SUSPENSION LETTER WRITTEN
02th Jul 2024LETTER OF SUSPENSION E-MAILED
02th Jul 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02th Jul 2024TEAS/EMAIL CORRESPONDENCE ENTERED
18th Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
18th Apr 2024NON-FINAL ACTION E-MAILED
18th Apr 2024NON-FINAL ACTION WRITTEN
17th Apr 2024ASSIGNED TO EXAMINER